Information:
Fel:
ID
14653
Beskrivning
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00841113
Länk
https://clinicaltrials.gov/show/NCT00841113
Nyckelord
Versioner (1)
- 2016-04-25 2016-04-25 -
Uppladdad den
25 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostate Cancer NCT00841113
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Prostate Cancer and its treatment
Item
histologically proven prostate cancer and not previously treated with hormones
boolean
C0600139 (UMLS CUI [1])
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
Advanced disease or metastases
Item
evidance of advanced disease or metastases
boolean
C0679246 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
C0027627 (UMLS CUI [2])
Life expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Serum testosterone measurement
Item
normal serum testosterone levels
boolean
C0428413 (UMLS CUI [1])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Hormone therapy and chemotherapy
Item
previous endocrine or cytoxic theapy for prostate cancer
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Cancer complication
Item
known tumour complication of prostate cancer which owuld require immediate treatment
boolean
C0596237 (UMLS CUI [1])
Further malignancy
Item
another malignancy other than basal cell cancer
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
Allergies
Item
history of significant drug hypersensitivity to either lhrh agonists or gnrh antagonists.
boolean
C0020517 (UMLS CUI [1,1])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])
Coagulation disorder
Item
congenital or acquired coagulation disorders contraindicating intramuscular injections
boolean
C0005779 (UMLS CUI [1])
Pagets disease
Item
pagets disease of the bone
boolean
C0029401 (UMLS CUI [1])
QTcB
Item
qtcb > 450 msec at day - 14
boolean
C1882512 (UMLS CUI [1])